Emergent CDMO is dedicated to helping pharma and biotech innovators bring life-saving, life-extending therapies to patients throughout the world. We have supported the development and manufacture of over 40 commercial and more than 200 clinical programs for our partners.

Products, services, technology

Development:
Process & Analytical development
Formulation & lyophilization development
Small-scale DS&DP manufacturing

Drug Substance:
SUB's up to 4'000L
Single-use downstream technologies

Drug Product:
Fill/finish (Vial & PFS)
Lyophilization
High containment filling (incl. BSL-2)
Final Packaging

Cooperation possibilities

From initial process & analytical development, to clinical through commercial manufacturing of Viral Vectors, Vaccines and Protein Drug Substance and sterile Drug Product supply, our experienced CDMO team can help guide your project successfully through all stages of the drug development lifecycle.

Location

Oberriedstrasse 68, 3174 Thörishaus, Switzerland

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    1998
  • Number of employees in Switzerland
    50-149